Extracellular vesicle surface display of αPD‐L1 and αCD3 antibodies via engineered late domain‐based scaffold to activate T‐cell anti‐tumor immunity.

MLA

Chen, Rui, et al. “Extracellular Vesicle Surface Display of ΑPD‐L1 and ΑCD3 Antibodies via Engineered Late Domain‐based Scaffold to Activate T‐cell Anti‐tumor Immunity.” Journal of Extracellular Vesicles, vol. 13, no. 7, July 2024, pp. 1–21. EBSCOhost, https://doi.org/10.1002/jev2.12490.

APA

Chen, R., Kang, Z., Li, W., Xu, T., Wang, Y., Jiang, Q., Wang, Y., Huang, Z., Xu, X., & Huang, Z. (2024). Extracellular vesicle surface display of αPD‐L1 and αCD3 antibodies via engineered late domain‐based scaffold to activate T‐cell anti‐tumor immunity. Journal of Extracellular Vesicles, 13(7), 1–21. https://doi.org/10.1002/jev2.12490

Chicago

Chen, Rui, Ziqin Kang, Wenhao Li, Tianshu Xu, Yongqiang Wang, Qiming Jiang, Yuepeng Wang, Zixian Huang, Xiaoding Xu, and Zhiquan Huang. 2024. “Extracellular Vesicle Surface Display of ΑPD‐L1 and ΑCD3 Antibodies via Engineered Late Domain‐based Scaffold to Activate T‐cell Anti‐tumor Immunity.” Journal of Extracellular Vesicles 13 (7): 1–21. doi:10.1002/jev2.12490.